CM082: Clinical Trials

4 trials of CM082, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 unknown, 1 not yet recruiting, 1 suspended. 4 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 14Unknown 2, Not yet recruiting 1, Suspended 1
Phase 21Not yet recruiting 1

Follow CM082: new trials by email Literature Review of CM082 trials Research Report on CM082

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Vorolanib Combined With Cadonilimab in the Treatment of Untreated Advanced RCC Patients
Vorolanib, cadonilimab - Kidney Cancer, RCC
Phase 1 / Phase 2Not yet recruitingCancer Institute and Hospital, Chinese Academy of Medical Sciences372024-08-312024-08-29
CM082 in Patients With Myopic Choroidal Neovascularization (CNV)
CM082 - Myopic Choroidal Neovascularisation
Phase 1SuspendedAnewPharma962019-12-182021-03-10
Study of Challenge Meditech 082 (CM082) Tablets in Patients With Advanced Malignant Solid Tumors
CM082 - Advanced Malignant Solid Tumors
Phase 1UnknownAnewPharma192019-02-262022-11-14
Study of the Combination of CM082 With Everolimus in Patients With mRCC
CM082, Everolimus - Renal Cell Carcinoma Recurrent
Phase 1UnknownAnewPharma182015-09-012018-01-10

Conditions studied

Carcinoma, Renal Cell (1)  ·  Kidney Neoplasms (1)

Sponsors

AnewPharma (3)  ·  Cancer Institute and Hospital, Chinese Academy of Medical Sciences (1)

Countries

China (3)

Top investigators

Jin Li, M.D (1)  ·  Jun Guo, M.D (1)  ·  Xinan Sheng, M.D (1)  ·  Youxin Chen (1)